Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection. by Vasileva, Hristina et al.
RESEARCH Open Access
Conjunctival transcriptome profiling of
Solomon Islanders with active trachoma in
the absence of Chlamydia trachomatis
infection
Hristina Vasileva1, Robert Butcher1* , Harry Pickering1, Oliver Sokana2, Kelvin Jack2, Anthony W. Solomon1,
Martin J. Holland1 and Chrissy h. Roberts1
Abstract
Background: Clinical signs of active (inflammatory) trachoma are found in many children in the Solomon Islands,
but the majority of these individuals have no serological evidence of previous infection with Chlamydia trachomatis.
In Temotu and Rennell and Bellona provinces, ocular infections with C. trachomatis were seldom detected among
children with active trachoma; a similar lack of association was seen between active trachoma and other common
bacterial and viral causes of follicular conjunctivitis. Here, we set out to characterise patterns of gene expression at
the conjunctivae of children in these provinces with and without clinical signs of trachomatous inflammation-
follicular (TF) and C. trachomatis infection.
Methods: Purified RNA from children with and without active trachoma was run on Affymetrix GeneChip Human
Transcriptome Array 2.0 microarrays. Profiles were compared between individuals with ocular C. trachomatis
infection and TF (group DI; n = 6), individuals with TF but no C. trachomatis infection (group D; n = 7), and
individuals without TF or C. trachomatis infection (group N; n = 7). Differential gene expression and gene set
enrichment for pathway membership were assessed.
Results: Conjunctival gene expression profiles were more similar within-group than between-group. Principal
components analysis indicated that the first and second principal components combined explained almost
50% of the variance in the dataset. When comparing the DI group to the N group, genes involved in T-cell
proliferation, B-cell signalling and CD8+ T cell signalling pathways were differentially regulated. When comparing the
DI group to the D group, CD8+ T-cell regulation, interferon-gamma and IL17 production pathways were enriched.
Genes involved in RNA transcription and translation pathways were upregulated when comparing the D group to the
N group.
Conclusions: Gene expression profiles in children in the Solomon Islands indicate immune responses consistent with
bacterial infection when TF and C. trachomatis infection are concurrent. The transcriptomes of children with TF but
without identified infection were not consistent with allergic or viral conjunctivitis.
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Background
Trachoma, caused by Chlamydia trachomatis (Ct), is the
most common infectious cause of blindness worldwide,
responsible for an estimated 1.9 million cases of blind-
ness or visual impairment [1]. Ocular infection with Ct
predominantly occurs in young children and triggers fol-
licular and papillary inflammation. Repeated rounds of
infection, inflammation and disease resolution lead to
deposition of scar tissue on the conjunctiva (trachoma-
tous scarring, TS) which accumulates with time; ultim-
ately distorting the eyelid and, in severe cases, bringing
the eyelashes into contact with the globe of the eye
(trachomatous trichiasis, TT). Abrasion by these lashes
can cause opacity (corneal opacity, CO) and blindness.
Trachoma is treated with a package of interventions
aimed at controlling infection and reducing the risk of
blindness from TT, collectively termed the SAFE strat-
egy. These include eyelid Surgery for those with TT,
community-wide Antibiotic distribution, promotion of
Facial cleanliness and Environmental improvement [2].
In a 2013 survey of children aged 1–9 years in Temotu
and Rennell and Bellona provinces of the Solomon
Islands, we found that more than a quarter (26.1%) of
those examined had the active (inflammatory) trachoma
sign trachomatous inflammation–follicular (TF). This
level of endemicity was high enough to warrant treatment
of the whole population by mass drug (azithromycin) ad-
ministration, but the prevalence of the more severe active
trachoma sign trachomatous inflammation–intense (TI;
0.2%) and ocular Ct infection (1.3%) was unusually low
given the TF prevalence [3]. In two consecutive surveys of
this population we consistently found that over 90% of TF
cases occurred in individuals who had no PCR detectable
ocular Ct infection. We also assessed the blood levels of
anti-Pgp3 antibodies, a putative serological marker of life-
time Ct exposure [4]. We found that TF was not associ-
ated with Pgp3 seropositivity. These data suggested that
the majority of TF cases that we identified were in individ-
uals who were very unlikely to have ever been exposed to
any form of Ct infection [5]. When we tested for the
presence of several other infectious micro-organisms
that are known to be able to cause symptoms of follicular
inflammation (Haemophilus influenzae, Streptococcus
pneumoniae, Moraxella catarrhalis, Staphylococcus spp.
and Adenoviridae), we found no association between TF
and any of these bacteria and viruses. A broad screen for
changes in bacterial communities of the conjunctiva in TF
cases was similarly null [6]. It could therefore be reason-
ably concluded that TF in this population is unlikely to be
linked to any bacterial infection.
The grading of TF was conducted by graders trained
to the same international standards as graders in other
countries, giving us no reason to suspect the TF pheno-
type in the Solomon Islands is different to that in
trachoma-endemic populations elsewhere in the world
[3]. However, we observed very little TS in the Solomon
Islands [5]. Therefore, an important question that
emerges from our work is whether there are differences
in the underlying immune response that could explain
why, in the Solomon Islands, highly prevalent TF does
not seem to be concurrent with the same burden of
blinding sequelae of trachoma as in other countries.
Previous work has described the typical host immune
response to ocular infection with Ct, a response that can
persist for weeks to months after the infection is re-
solved [7]. While the frequency and duration of Ct infec-
tion decrease with age, inflammation can be found in a
significant fraction of older people, and is associated
with progression of scarring [7, 8]. The clearance of Ct
infection is generally accepted to be mediated by inter-
feron gamma (IFNγ) [9–11] with epithelial and lymphoid
cells generating a strong pro-inflammatory Type 1 re-
sponse that includes production of growth factors, such
as platelet-derived growth factor (PDGF), connective-
tissue growth factor (CTGF) and tumour necrosis factor
alpha (TNFα) [12–15]. Prolonged activation of these re-
sponses leads to the formation of the lymphoid follicles
that characterise TF. Studies have also shown upregula-
tion of major histocompatibility complex (MHC) class I
expression, the induction of MHC class II in cells in
which it is normally absent, as well as the expression of
genes typical of neutrophils and natural killer (NK) cell
cytotoxicity [13, 16]. Other types of conjunctivitis (i.e.
those not caused by Ct infection) have different under-
lying immune pathologies and are characterised by quite
distinct transcriptomic signatures. Allergic conjunctivitis,
for instance, is characterised by eosinophilic inflamma-
tion, mast cell degranulation, upregulation of adhesion mol-
ecules and production of chemokines [17–19]. Conversely,
in vitro transcriptional profiling studies of adenoviral infec-
tion of human epithelial cells indicate dominance of anti-
viral and type-one interferon-associated pathways [20].
We hypothesised that gene expression profiles of TF
in the Solomon Islands could help us to determine
whether TF in children from the Solomon Islands is
caused by bacteria, viruses or allergens.
Methods
Specimen collection
Specimens were collected during a population-based
prevalence survey for trachoma in Temotu and Rennell
and Bellona provinces of the Solomon Islands which
took place in 2013 [3]. Clinical grades were assigned in
the field by Global Trachoma Mapping Project-certified
graders according to the WHO simplified grading
scheme [21, 22]. All clinical data and methods relating
to the 2013 survey have been published elsewhere [3].
Briefly, we used polyester-coated cotton swabs to collect
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conjunctival specimens from 1002 1–9-year-olds. Swabs
were collected from the everted right conjunctiva and
placed immediately into 300 μl RNAlater, then kept cool
in the field and frozen within 48 h of collection. Speci-
mens were shipped on dry ice to the UK for processing.
Case-control selection
From the whole population sample, three subsets of
specimens were selected for the microarray-based gene
expression profiling experiment. Group N (n = 7) were
children who had neither TF, nor Ct infection [3], nor
any of other common ocular infections (as listed in the
introduction) [6]. Group D (n = 7) were children who
did have TF, but had neither Ct nor any of the other
infections.
Two years after the initial survey, all individuals in
groups D and N were revisited by chance during a sero-
logical survey and were tested for evidence of prior Ct
infections with an anti-Pgp3 ELISA test [5]. All members
of groups D and N were seronegative at that time, sug-
gesting that no member of either group had previously
been infected with Ct. The third group DI (n = 6) had
both clinical signs of TF (but not TI) and current ocular
Ct infection during the 2013 survey. The mean Ct load
in the 6 DI conjunctival samples was 338 omcB copies/
μl (range: 0.4–1121 omcB copies/μl). The detected strain
in all 6 DI samples were serovar C according to ompA
sequence, and were most closely related to Ct A/HAR-
13 within the T2 ocular clade when aligned at the
whole-genome level [3]. We had very few Ct infection
cases to choose from, so we were unable to stringently
filter the DI group to ensure that no ‘other infections’
were present. Three of the DI group members had no
other infections besides Ct, one had S. pneumoniae
present, one had H. influenzae, and one had Adenovirus
and H. influenzae present. All of these infections were
low load (< 5 copies/μl). None of the six members of
group DI participated in the 2015 follow-up survey.
Participants were age- and gender-matched between
groups (Kruskall-Wallis test, χ2 = 0.31804, df = 2, P = 0.853
and χ2 = 2.6412, df = 2, P = 0.267, respectively).
RNA extraction and quantification
DNA and total RNA from each sample were simultan-
eously extracted using the Qiagen AllPrep Mini protocol
(Qiagen, Hilden, Germany). DNA extracts were tested
for Ct infection using a droplet digital PCR (ddPCR)
assay [23] which we have previously used in both high
[24, 25] and low endemicity settings [3, 26]. The diag-
nostic performance of the in-house ddPCR assay, pub-
lished elsewhere, has a demonstrated sensitivity of 97.1%
and specificity of 90.0% in low endemicity areas [27].
Purified RNA was stored at -80 °C before testing. The
quantity and quality of RNA was calculated using
Agilent RNA 6000 Pico Assay according to the manufac-
turer’s protocol (Agilent, Santa Clara, USA).
Probe library preparation
RNA samples were normalised and used as a template
for the generation of cDNA using NuGEN Ovation Pico
WTA System V2 protocol (NuGEN, Leek, Netherlands).
cDNA was amplified and purified using Agencourt
RNAClean XP (Beckman Coulter, High Wycombe, UK)
followed by QIAGEN QIAquick PCR Purification (Qia-
gen, Hilden, Germany).
cDNA fragmentation and labelling was performed
according to FL-Ovation™ cDNA Biotin Module V2
protocol (NuGEN, Leek, Netherlands). Biotinylated
cDNA was hybridised to GeneChip HTA 2.0 microarrays
according to the NuGEN Hybridization, Cocktail Assembly
and Fluidics Protocol for single arrays (NuGEN, Leek,
Netherlands). The hybridized arrays were washed and
stained with streptavidin-phycoerythrin (SAPE) in a
Fluidex GeneChip 450 according to the GeneChip®
Expression Analysis protocol (Thermo Fisher Scientific,
Hemel Hempsted, UK). Goat anti-biotin-SAPE antibodies
(IgG) were used for signal amplification.
Microarray data processing
The GeneChip HTA 2.0 array contains approximately 1.7
million probe sets, represented by 70,523 human tran-
script clusters [28]. Analysis of array data was conducted
using Bioconductor and R software packages [29, 30].
Mean microarray average plots were visually inspected to
ensure consistency and quality of hybridization intensity
between arrays. Array data files were normalized using
Robust Multichip Average (RMA) algorithms from the
Bioconductor package “oligo” [31]. Transcript clusters
were annotated using the ‘hta20transcriptcluster.db’
Bioconductor package. Normalized transcript clusters
without annotation information, those with no detected
signal and array endogenous controls were discarded from
the overall data set. Where more than one transcript clus-
ter mapped to a single accession number, the transcript
cluster with the highest fluorescence intensity was
retained and the others discarded. Of the resultant tran-
script clusters, those with an RMA-normalised intensity
interquartile range of < 0.1 across all samples were also
removed [30].
Identification of differentially expressed genes
Group mean hybridization intensities of each transcript
were compared in a pairwise manner between the DI, D
and N sample groups, applying empirical Bayes moderated
t-test for mean difference [32] using the Bioconductor
package “limma” [33]. To account for multiple testing of
large number of variables, a corrected P-value for each
transcript was obtained by subjecting the P-values
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from each comparison to a permutation analysis [34].
Transcript clusters with a corrected P-value lower
than the selected threshold of < 0.05 for each comparison
were considered differentially expressed (DE) [35].
Directionality of DE gene regulation was determined
by gene log2 fold change (log2FC) of expression fluc-
tuating above (upregulated) and below (downregu-
lated) log2FC = 1. DE genes from all three
comparisons (DI vs D, DI vs N, D vs N) were com-
bined for the purposes of visualizing the differences
in global gene expression between groups. Principal
components analysis (PCA) was used to visualise dif-
ferences in transcriptomes between samples according
to variance between gene expression levels of total
DE genes [36]. PCA was used to identify whether the
phenotypic groups could be separated according to
variance in total DE genes expression profiles. Group
separation was tested using ordinal logistic regression,
using the “MASS” package in R [37].
Biological function of differentially expressed genes
Lists of DE gene GenBank accession numbers were sub-
jected to Gene Ontology (GO) terms analysis, using
Database for Annotation, Visualization and Integrated
Discovery (DAVID) v6.8 [38]. GO terms were considered
statistically significant based on Benjamini’s adjusted P-
value < 0.05. The top five statistically significant genetic
pathways for the DE genes in each comparison were
identified using Kyoto Encyclopaedia of Genes and
Genomes (KEGG) bioinformatics database [39].
Results and Discussion
Following comparison of transcript clusters hybridisa-
tion intensities between groups, a combined total of
7761 DE genes were identified. The number of genes per
group is summarized in Table 1 and the comparison of
DE gene expression across all samples is visualised as a
heat map in Fig. 1a. Most samples appeared to be more
similar within-group than between-groups, with some
exceptions (samples DI3, DI4, N1 and N2). There were
no significant differences between chlamydial load
(Mann-Whitney U-test, U = 3, n1 = 2, n2 = 4, P = 0.8),
nor between the age or gender of the participants from
whom samples DI3 and DI4 came from, compared with
the rest of the DI group specimens. The same was
Table 1 Differentially expressed (DE) genes in each group comparison, separated according to the direction and magnitude of
change
Comparison DI vs D (n = 2368) DI vs N (n = 6371) D vs N (n = 1933)
Upregulated genes n (%) 1388 (58.6) 2777 (43.6) 700 (36.2)
log2FC, mean (min-max) 0.378 (0.067–2.971) 0.437 (0.072–2.694) 0.322 (0.064–1.477)
Downregulated genes n (%) 980 (41.4) 3594 (56.4) 1233 (63.8)
log2FC, mean (min-max) −0.346 (− 3.686– −0.065) −0.294 (− 3.901– −0.054) −0.230 (−1.436– −0.054)
Fig. 1 a Heat map visually representing the gene expression intensity of
total differentially expressed genes, (n= 7761) in each array sample. Red
indicates high expression, blue indicates low expression. b Principal
components analysis of differentially expressed genes in children with
and without TF and Ct infection in the Solomon Islands (n= 20). Point
colour indicates the clinical phenotype whilst the size of the point is
proportional to the load of Ct infection in specimens within the DI group
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observed for samples N1 and N2 compared with the
other samples from the N group. As no significant dif-
ferences in the demographics of the group members that
might account for the observed differences in gene ex-
pression pattern can be identified, we suggest this is
likely to be due to natural within-group heterogeneity.
Figure 1b shows a bi-plot of the first two principal com-
ponents (PCs) which cumulatively describe 47% (PC1:
36%, PC2: 11%) of the total between-group variance in
gene expression. Each coloured point represents one of
the specimens. There are visible separations between
clusters of specimens which have similar phenotypes.
We observed substantial gene expression profile differ-
ences between the DI, D and N groups (Fig. 1). The KEGG
pathway analysis is summarised in Table 2. Our data show
that the most enriched pathways observed when compar-
ing the DI group with the D and N groups are closely
linked to key elements of the immune response, including
IL17 and IFNγ production, genes controlling T-cell prolif-
eration/response and B-cell signalling. The D group,
which had no evidence of current or previous Ct infection,
was not enriched for the same pathways when compared
to the N group. Surprisingly, individuals with visible sub-
conjunctival lymphoid follicles had no enrichment of
pathways related to lymphocyte activation, nor upregu-
lated genes associated with activation and recruitment of
NK and dendritic cells (CCL18), fundamental for TF [13].
In the Ct-infected (DI) group we saw some patterns of
Table 2 Biological pathways (GO terms and KEGG pathways) showing significant enrichment across three between-group
comparisons
Comparison
(No. of genes)
Principal GO terms Fold enrichment Adjusted P-value Principal KEGG pathways P-value
DI vs D
(n = 2368)
GO:0039692: ssRNA viral replication 6.93 2.23 × 10−2 hsa04658: Th1 and Th2
cell differentiation
6.80 × 10−7
GO:2,001,185: regulation of CD8+
T-cells
6.93 2.23 × 10−2 hsa04110: Cell cycle 4.33 × 10−6
GO:0072643: IFNγ secretion 5.78 2.34 × 10−3 hsa05203: Viral carcinogenesis 1.40 × 10−4
GO:0007076: mitotic chromosome
condensation
5.39 2.70 × 10−2 hsa04114: Oocyte meiosis 2.19 × 10−4
GO:0046633: T-cell proliferation 5.33 2.65 × 10−2 hsa04612: Antigen processing
and presentation
3.16 × 10−4
GO:0032620: interleukin-17
production
4.16 2.30 × 10−2 hsa05166: HTLV-I infection 1.33 × 10−3
GO:1,901,976: regulation of cell cycle 3.50 3.65 × 10−2 hsa05340: Primary immunodeficiency 3.12 × 10−03
DI vs N
(n = 6371)
GO:0036037: CD8+ T-cell activation 2.88 3.59 × 10−3 hsa04750: Inflammatory mediator
regulation of TRP channels
1.22 × 10−3
GO:0006270: DNA replication
initiation
2.41 4.18 × 10−3 hsa03030: DNA replication 2.06 × 10−3
GO:0045047: Protein targeting to ER 2.07 1.11 × 10−5 hsa03040: Spliceosome 2.06 × 10−3
GO:0019080: Viral gene expression 1.98 4.53 × 10−9 hsa04612: Antigen processing and
presentation
2.38 × 10−3
GO:0050853: B-cell receptor signalling
pathway
1.83 3.19 × 10−2 hsa04925: Aldosteron synthesis and
secretion
3.02 × 10−3
GO:0048477: oogenesis 1.74 2.60 × 10−2 hsa04658: Th1 and Th2 cell differentiation 5.50 × 10−3
GO:0042098: T-cell proliferation 1.65 6.17 × 10−4 hsa04110: Cell cycle 5.70 × 10−3
D vs N
(n = 1933)
GO:0045047: Protein targeting to ER 6.59 2.41 × 10−20 hsa03010: Ribosome 1.18 × 10−11
GO:0019083: Viral gene expression 4.37 1.89 × 10−18 hsa04612: Antigen processing and
presentation
1.34 × 10−3
GO:0042255: ribosome assembly 3.92 9.50 × 10−4 hsa03030: DNA replication 2.42 × 10−2
GO:0042254: ribosome biogenesis 2.50 8.99 × 10−8 hsa03040: Spliceosome 5.53 × 10−2
GO:0043043: peptide biosynthetic
process
1.92 1.37 × 10−6 hsa05332: Graft-versus-host disease 5.53 × 10−2
GO:0006396: RNA processing 1.81 2.26 × 10−7 hsa05416: Viral myocarditis 8.33 × 10−2
GO:0033365: Protein localization
to organelle
1.63 1.62 × 10−4
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pathway enrichment that closely resembled data from
other trachoma-endemic populations [8, 13]. However,
whilst IL17 and IFNγ pathways were upregulated in the
Solomon Islands, key pro-fibrotic markers and genes en-
coding extracellular matrix molecules (MMP7, MMP9,
MMP12) were not found to be differentially regulated, nor
were their associated pathways enriched [13]. These path-
ways are typical of scarring disease, but are also upregu-
lated during and after Ct infection in young people
with inflammatory trachoma [40].
Previous studies have shown that thymic stromal lym-
phoprotein (TSLP), IL-4, IL-5 and IL-13 are upregulated
during episodes of allergic or seasonal conjunctivitis
[41], but these were not significantly differentially regu-
lated in the D group when compared to the N group nor
the DI group when compared to the D group. We did
not identify any key pathways associated with eosino-
philic inflammation, IgE release or degranulation of mast
cells and we therefore do not suspect allergic responses
to be playing a significant role in the TF phenotype in
these children. The predominant pathways that showed
highly significant enrichment in the D group, when com-
pared with the N group, were viral gene expression path-
ways as well as protein biosynthesis pathways centring
around ribosome function. However, anti-viral immunity
and type one interferon-dependent pathways were not
enriched according to this analysis. Viral pathways were
also enriched in the DI group when compared to the N
and D groups, although these were less significant.
There is deep redundancy and overlap of gene content
in the GO and KEGG pathways, which means that their
names can often be misleading with regards to their
roles in a specific clinical context. On that basis, we do
not have strong evidence that an as-yet uncharacterised
viral infection may be responsible for the observed dis-
crepancy between phenotype and Ct infection. This
study was limited by small sample size and in some
cases the additional diagnosis of other ocular infections
that can cause TF-like clinical signs. However, the
natural heterogeneity of the data is typical of complex
human disease studies and the transcriptional profiles of
those with disease and Ct infection were sufficiently
similar to those seen in other populations.
The World Health Organization guidelines for imple-
menting mass drug administration (MDA) are based
largely on TF prevalence. We have previously argued that
whilst the Solomon Islands has sufficiently prevalent clin-
ical signs (TF) of trachoma to qualify for implementation
of MDA, the prevalence of infection and trichiasis [3, 5], as
well as severe scarring and serological signs of prior infec-
tion [6] are all too low to suggest that clinical diagnosis
with TF has the necessary specificity to be used as an indi-
cator of need for intervention in this population. By show-
ing that the transcriptional profile of TF (Ct uninfected)
cases in the Solomon Islands share some, but not all, the
components of typical trachoma responses seen elsewhere,
the current findings add to those of our previous studies to
suggest that the majority of TF disease we observe there is
not related to Ct. We believe that there is potential that
similar disease could occur elsewhere and would recom-
mend that a diagnostic test for ocular infection should be
considered for routine use in combination with clinical
signs of the disease, in order to better inform the decision
to treat a population with MDA.
Conclusions
Our recent studies identified that the majority of TF disease
in the Solomon Islands could be attributed to neither Ct
[3], nor any of several common ocular microbes, nor
polymicrobial community [6]. We hypothesised that TF in
the absence of current Ct infection in the Solomon Island
population would have a transcriptional profile that could
indicate either an allergic or viral trigger. The host
responses we measured did not provide any indication for
the involvement of an allergic response, nor was there
convincing evidence for a response to a viral infection. The
results suggest that further studies in to the aetiology of
disease in this context are warranted.
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